Literature DB >> 12494927

World status of monitoring iodine deficiency disorders control programs.

François Delange1, Hans Bürgi, Zu Pei Chen, John T Dunn.   

Abstract

Monitoring and evaluation are the last phases of a national iodine deficiency disorders (IDD) control program but among the most important. This paper summarizes the latest recommendations by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF), and the International Council for Control of Iodine Deficiency Disorders (ICCIDD) about indicators and their normative values for monitoring the progress of IDD elimination and illustrates the successful monitoring programs in Switzerland and in China. Salt is the usual vehicle for iodine supplementation and quality control for iodine content can be assessed quantitatively by titration and qualitatively by simple test kits that can be used in the field. The most useful indicator of iodine nutrition is the median urinary iodine concentration. Thyroid size, especially by ultrasound, and neonatal thyrotropin (TSH) are also valuable. In Switzerland, access to iodized salt on a voluntary basis started in 1922. The initial level of iodization, 1.9-3.75 ppm iodine as potassium iodide (KI), was slowly increased to 15 ppm, and recently to 20 ppm, after careful epidemiologic and biologic monitoring. Elimination of IDD has been highly successful. The program costs US dollars 0.07 per year per person. In China, a national program of iodized salt (10-30 ppm) started in 1960 under the authority of the central government and rapidly expanded. National monitoring surveys have taken place every 2 years since 1993. Median urinary iodine, initially low, increased to 165 microg/L in 1995 and to 306 microg/L in 1999, prompting a decrease in the amount of iodine added to salt. The total goiter rate decreased to 20.4% in 1995 and to 8.8% in 1999. IDD can presently be considered as eliminated in China. Review of monitoring in the 128 other major countries affected by IDD shows extremely variable achievements, with evidence of IDD elimination in at least 18 additional countries. Some countries that were severely iodine deficient in the past are now exposed to iodine excess and risk its effects. Sustainable elimination of IDD is within reach and would constitute an unprecedented global success story in the field of noncommunicable diseases, but continuing vigorous action is required to attain this goal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12494927     DOI: 10.1089/105072502761016557

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  27 in total

1.  Attention to the hiding iodine deficiency in pregnant and lactating women after universal salt iodization: A multi-community study in China.

Authors:  Y Q Yan; Z P Chen; X M Yang; H Liu; J X Zhang; W Zhong; W Yao; J K Zhao; Z Z Zhang; J L Hua; J S Li; X Q Yu; F R Wang
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

Review 2.  Transient hypothyroidism in the newborn: to treat or not to treat.

Authors:  Neelakanta Kanike; Ajuah Davis; Prem S Shekhawat
Journal:  Transl Pediatr       Date:  2017-10

Review 3.  Iodine-induced thyroid dysfunction.

Authors:  Angela M Leung; Lewis E Braverman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-10       Impact factor: 3.243

Review 4.  The changing epidemiology of iodine deficiency.

Authors:  Mu Li; Creswell J Eastman
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

5.  Do thyroxine and thyroid-stimulating hormone levels reflect urinary iodine concentrations?

Authors:  Offie P Soldin; Rochelle E Tractenberg; John C Pezzullo
Journal:  Ther Drug Monit       Date:  2005-04       Impact factor: 3.681

6.  Youth of West Cameroon are at high risk of developing IDD due to low dietary iodine and high dietary thiocyanate.

Authors:  Ibrahim Taga; Valere Aime Soh Oumbe; Robert Johns; Mohsin Abbas Zaidi; Ngogang Jeanne Yonkeu; Illimar Altosaar
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

Review 7.  The Na+/I- symporter (NIS): mechanism and medical impact.

Authors:  Carla Portulano; Monika Paroder-Belenitsky; Nancy Carrasco
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

8.  Effects of prophylaxis with iodised salt in an area of endemic goitre in north-eastern Sicily.

Authors:  C Regalbuto; G Scollo; G Pandini; R Ferrigno; V Pezzino
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

9.  An adequacy evaluation of a 10-year, four-country nutrition and health programme.

Authors:  Peter R Berti; Alison Mildon; Kendra Siekmans; Barbara Main; Carolyn Macdonald
Journal:  Int J Epidemiol       Date:  2010-03-03       Impact factor: 7.196

10.  Youth of west-Cameroon are at high risk of developing IDD due to low dietary iodine and high dietary thiocyanate.

Authors:  Ibrahim Taga; Valere Aime Soh Oumbe; Robert Johns; Mohsin Abbas Zaidi; Jeanne Ngogang Yonkeu; Illimar Altosaar
Journal:  Afr Health Sci       Date:  2008-09       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.